Glaucoma Therapeutics Market Size, Share, Trends & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100312

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2016-2027
Base Year	2019
Forecast Period	2020-2027
Historical Period	2016-2018
Unit	Value (USD billion)
Segmentation	By Drug Class Beta Blockers Prostaglandins Analogs Latanoprost Bimatoprost Travoprost Others Alpha Adrenergic Agonists Carbonic Anhydrase Inhibitors Combination Drugs Others
	By Disease Indication Open Angle Glaucoma Angle Closure Glaucoma Others
	By Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy
	By Geography North America (U.S and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) Asia-Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia- Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East and Africa (GCC countries, South Africa, and Rest of the Middle East and Africa)